Skip to Content

42 Results Found

  • Editorial
  • Open Access
45 Citations
6,132 Views
4 Pages

Model-Informed Precision Dosing (MIPD)

  • Jonás Samuel Pérez-Blanco and
  • José M. Lanao

Model-informed precision dosing (MIPD) is an advanced quantitative approach focusing on individualized dosage optimization, integrating complex mathematical and statistical models of drugs and disease combined with individual demographic and clinical...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
11 Citations
3,427 Views
14 Pages

30 September 2022

Model-informed precision dosing (MIPD) can aid dose decision-making for drugs such as gentamicin that have high inter-individual variability, a narrow therapeutic window, and a high risk of exposure-related adverse events. However, MIPD in neonates i...

(This article belongs to the Special Issue Dosing Strategies for Protecting the Vulnerable)
  • Article
  • Open Access
3 Citations
4,031 Views
17 Pages

Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins

  • Juliana Queiroz da Silva,
  • Natália Valadares de Moraes,
  • Rita Estrela,
  • Diogenes Coelho and ,
  • Diego Feriani,
  • Karen Migotto,
  • Pedro Caruso,
  • Ivan Leonardo França e Silva,
  • Daiane de Araujo Oliveira and
  • Fernanda de Lima Moreira
  • + 6 authors+ 1 author

Background/Objectives: Guidelines recommend adjusting amikacin dosing based on patients’ renal function. Nevertheless, for critically ill cancer patients, the renal function equations based on serum creatinine levels have low or no correlation...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
2 Citations
1,861 Views
12 Pages

14 January 2026

Background: Tobramycin is a key therapy for pulmonary exacerbations in children and adolescents with cystic fibrosis (CF), yet its variable pharmacokinetics (PK) combined with narrow therapeutic index necessitates therapeutic drug monitoring (TDM) du...

(This article belongs to the Special Issue Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine)
  • Article
  • Open Access
1 Citations
1,372 Views
15 Pages

Background: Staphylococcal bloodstream infections (BSIs) and infective endocarditis (IE) are associated with high morbidity and mortality. Among the different antimicrobial combination strategies proposed to enhance antibacterial activity, the associ...

(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)
  • Article
  • Open Access
18 Citations
3,577 Views
19 Pages

Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis

  • Jaewoo Kwon,
  • Ki Byung Song,
  • Seo Young Park,
  • Dakyum Shin and ,
  • Sarang Hong,
  • Yejong Park,
  • Woohyung Lee,
  • Jae Hoon Lee,
  • Dae Wook Hwang and
  • Song Cheol Kim
  • + 5 authors+ 0 author

15 April 2020

Background: Few studies have compared perioperative and oncological outcomes between minimally invasive pancreatoduodenectomy (MIPD) and open pancreatoduodenectomy (OPD) for pancreatic ductal adenocarcinoma (PDAC). Methods: A retrospective review of...

(This article belongs to the Special Issue Pancreatic Ductal Adenocarcinoma)
  • Article
  • Open Access
10 Citations
4,219 Views
11 Pages

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis

  • Ruben Faelens,
  • Zhigang Wang,
  • Thomas Bouillon,
  • Paul Declerck and ,
  • Marc Ferrante,
  • Séverine Vermeire and
  • Erwin Dreesen
  • + 2 authors+ 0 author

Model-informed precision dosing (MIPD) may be a solution to therapeutic failure of infliximab for patients with ulcerative colitis (UC), as underexposure could be avoided, and the probability of endoscopic improvement (pEI; Mayo endoscopic subscore ≤...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Review
  • Open Access
39 Citations
8,049 Views
15 Pages

Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review

  • Paula Del Valle-Moreno,
  • Paloma Suarez-Casillas,
  • Marta Mejías-Trueba,
  • Pablo Ciudad-Gutiérrez and ,
  • Ana Belén Guisado-Gil,
  • María Victoria Gil-Navarro and
  • Laura Herrera-Hidalgo
  • + 2 authors+ 0 author

Background: Pharmacokinetic nomograms, equations, and software are considered the main tools available for Therapeutic Drug Monitoring (TDM). Model-informed precision dosing (MIPD) is an advanced discipline of TDM that allows dose individualization,...

(This article belongs to the Special Issue Therapeutic Drug Monitoring)
  • Article
  • Open Access
2 Citations
2,872 Views
10 Pages

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis

  • Jérémy Reverchon,
  • Vianney Tuloup,
  • Romain Garreau,
  • Viviane Nave and ,
  • Sabine Cohen,
  • Philippe Reix,
  • Stéphane Durupt,
  • Raphaele Nove-Josserand,
  • Isabelle Durieu and
  • Sylvain Goutelle
  • + 8 authors+ 3 authors

Therapeutic drug monitoring (TDM) of tobramycin is widely performed in patients with cystic fibrosis (CF), but little is known about the value of model-informed precision dosing (MIPD) in this setting. We aim at reporting our experience with tobramyc...

(This article belongs to the Special Issue Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy)
  • Review
  • Open Access
6 Citations
3,290 Views
13 Pages

Model-Informed Precision Dosing: Conceptual Framework for Therapeutic Drug Monitoring Integrating Machine Learning and Artificial Intelligence Within Population Health Informatics

  • Jennifer Le,
  • Hien N. Le,
  • Giang Nguyen,
  • Rebecca Kim and ,
  • Sean N. Avedissian,
  • Connie Vo,
  • Ba Hai Le,
  • Thanh Hai Nguyen,
  • Dua Thi Nguyen and
  • Amy M. Sitapati
  • + 12 authors+ 7 authors

31 January 2026

Background/Objective: Traditional therapeutic drug monitoring is limited by manual interpretation and specific constraints like sampling at steady-state and requiring a minimum of two drug concentrations. The integration of model-informed precision d...

(This article belongs to the Special Issue Artificial Intelligence for Personalized Medicine: Bridging Innovative Technologies and Patient-Centric Care)
  • Article
  • Open Access
2 Citations
3,034 Views
16 Pages

Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial

  • Sarah Dräger,
  • Tim M. J. Ewoldt,
  • Alan Abdulla,
  • Wim J. R. Rietdijk and ,
  • Nelianne Verkaik,
  • Christian Ramakers,
  • Evelien de Jong,
  • Michael Osthoff,
  • Birgit C. P. Koch and
  • Henrik Endeman
  • + 5 authors+ 0 author

Model-informed precision dosing (MIPD) might be used to optimize antibiotic treatment. Procalcitonin (PCT) is a biomarker for severity of infection and response to antibiotic treatment. The aim of this study was to assess the impact of MIPD on the co...

(This article belongs to the Special Issue Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine)
  • Review
  • Open Access
2 Citations
2,256 Views
17 Pages

7 January 2026

Background: Minimally invasive pancreatoduodenectomy (MIPD) has evolved from an experimental technique to a feasible surgical option for pancreatic cancer in selected settings. However, its oncologic adequacy, safety, and generalizability remain deba...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
17 Citations
4,585 Views
15 Pages

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

  • Laurynas Mockeliunas,
  • Lina Keutzer,
  • Marieke G. G. Sturkenboom,
  • Mathieu S. Bolhuis and ,
  • Lotte M. G. Hulskotte,
  • Onno W. Akkerman and
  • Ulrika S. H. Simonsson
  • + 2 authors+ 0 author

Linezolid is an efficacious medication for the treatment of drug-resistant tuberculosis but has been associated with serious safety issues that can result in treatment interruption. The objectives of this study were thus to build a population pharmac...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
3 Citations
1,834 Views
15 Pages

Artery-First Approach During Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Outcomes from a Single Center and Comparison Between Laparoscopic and Robotic Approaches

  • Michele Mazzola,
  • Michele Paterno,
  • Alessandro Giani,
  • Pietro Calcagno and ,
  • Andrea Zironda,
  • Gaia Mucci,
  • Camillo Franzetti,
  • Paolo De Martini and
  • Giovanni Ferrari
  • + 4 authors+ 0 author

23 June 2025

Background: Despite benefits during open pancreatoduodenectomy (PD), the artery-first approach (AFA) during minimally invasive PD (MIPD) has been poorly investigated. Methods: Data of consecutive patients undergoing MIPD (both laparoscopic (LPD) and...

(This article belongs to the Special Issue Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer)
  • Systematic Review
  • Open Access
2 Citations
1,245 Views
11 Pages

15 May 2026

Background: Bayesian model-informed precision dosing (MIPD) is increasingly used to individualize drug therapy; therefore, this review aimed to identify and characterize its implementation in routine clinical practice. Methods: A focused systematic r...

(This article belongs to the Special Issue Recent Advances in Clinical Pharmacology Based on Pharmacokinetics)
  • Article
  • Open Access
10 Citations
3,174 Views
13 Pages

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children

  • Sylvain Goutelle,
  • Yann Thoma,
  • Roxane Buffet,
  • Michael Philippe and ,
  • Thierry Buclin,
  • Monia Guidi and
  • Chantal Csajka
  • + 2 authors+ 0 author

Busulfan, a drug used in conditioning prior to hematopoietic stem cell transplantation (HSCT) in children, has a narrow therapeutic margin. The model-informed precision dosing (MIPD) of busulfan is desirable, but there is a lack of validated tools. T...

(This article belongs to the Special Issue Population Pharmacokinetics in Oncology and Its Clinical Applications)
  • Article
  • Open Access
5 Citations
2,791 Views
15 Pages

Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis

  • Karine Rodríguez-Fernández,
  • Javier Zarzoso-Foj,
  • Marina Saez-Bello,
  • Almudena Mateu-Puchades and ,
  • Antonio Martorell-Calatayud,
  • Matilde Merino-Sanjuan,
  • Elena Gras-Colomer,
  • Monica Climente-Martí and
  • Victor Mangas-Sanjuan
  • + 4 authors+ 0 author

Background/Objectives: Implementing model-informed precision dosing (MIPD) strategies guided by population pharmacokinetic/pharmacodynamic (PK/PD) models could enhance the management of inflammatory diseases such as psoriasis. However, the extent of...

(This article belongs to the Special Issue Population Pharmacokinetics and Its Clinical Applications)
  • Review
  • Open Access
1,084 Views
12 Pages

From Open to Robot-Assisted Pancreatoduodenectomy: What RCTs Really Show

  • Alice Cattelani,
  • Roberto M. Montorsi,
  • Alessio Marchetti,
  • Lucia Landi and ,
  • Federico Gronchi,
  • Matteo De Pastena,
  • Luca Landoni,
  • Alessandro Esposito,
  • Salvatore Paiella and
  • Roberto Salvia
  • + 6 authors+ 1 author

4 February 2026

Introduction: Minimally invasive pancreatoduodenectomy (MIPD), including laparoscopic (LPD) and robotic approaches (RPD), has gained increasing attention as an alternative to open pancreatoduodenectomy (OPD). Despite rapid technological progress, con...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Systematic Review
  • Open Access
18 Citations
2,905 Views
15 Pages

Minimally Invasive Pancreaticoduodenectomy in Elderly versus Younger Patients: A Meta-Analysis

  • Roberto Ballarin,
  • Giuseppe Esposito,
  • Gian Piero Guerrini,
  • Paolo Magistri and ,
  • Barbara Catellani,
  • Cristiano Guidetti,
  • Stefano Di Sandro and
  • Fabrizio Di Benedetto
  • + 3 authors+ 0 author

11 January 2024

(1) Background: With ageing, the number of pancreaticoduodenectomies (PD) for benign or malignant disease is expected to increase in elderly patients. However, whether minimally invasive pancreaticoduodenectomy (MIPD) should be performed in the elder...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
5 Citations
4,583 Views
11 Pages

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

  • Anna Mueller-Schoell,
  • Lena Klopp-Schulze,
  • Robin Michelet,
  • Madelé van Dyk and ,
  • Thomas E. Mürdter,
  • Matthias Schwab,
  • Markus Joerger,
  • Wilhelm Huisinga,
  • Gerd Mikus and
  • Charlotte Kloft
  • + 5 authors+ 0 author

3 February 2021

Tamoxifen is widely used in breast cancer treatment and minimum steady-state concentrations of its active metabolite endoxifen (CSS,min ENDX) above 5.97 ng/mL have been associated with favourable disease outcome. Yet, about 20% of patients do not rea...

(This article belongs to the Special Issue Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability)
  • Review
  • Open Access
13 Citations
6,910 Views
18 Pages

The appropriate use of antibiotics is crucial and involves selecting an optimal dosing regimen based on pharmacokinetic (PK) and pharmacodynamic (PD) indicators. Physiologically based pharmacokinetic (PBPK) modeling is a powerful tool that integrates...

(This article belongs to the Special Issue Clinical Pharmacokinetics, Pharmacodynamics, and/or TDM of Antimicrobial Agents)
  • Article
  • Open Access
2 Citations
2,937 Views
16 Pages

Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing

  • Karine Rodriguez-Fernandez,
  • Javier Zarzoso-Foj,
  • Marina Saez-Bello,
  • Almudena Mateu-Puchades and ,
  • Antonio Martorell-Calatayud,
  • Matilde Merino-Sanjuan,
  • Elena Gras-Colomer,
  • Monica Climente-Marti and
  • Victor Mangas-Sanjuan
  • + 4 authors+ 0 author

Background/Objectives: Patient care and control of inflammatory disorders, such as psoriasis, can be improved by model-informed precision dosing (MIPD) techniques based on population pharmacokinetic/pharmacodynamic (PK/PD) models. Clinical dose selec...

(This article belongs to the Special Issue Population Pharmacokinetics and Its Clinical Applications)
  • Article
  • Open Access
424 Views
9 Pages

Impact of Concomitant Thoracic Trauma on Functional Outcomes After Surgical Treatment of Glenoid Fractures

  • Haluk Yaka,
  • Muzaffer Harmankaya,
  • Hasan Rüzgar,
  • Ali Adem and ,
  • İnci Hazal Ayas,
  • Mustafa Özer and
  • Ulunay Kanatlı
  • + 2 authors+ 0 author

28 April 2026

Background/Objectives: The minimally invasive posterior deltoid-sparing (MIPDS) approach has been described for glenoid fractures; however, its outcomes for Ideberg type Ib, II, III, IV, and V fractures and the influence of concomitant injuries on fu...

(This article belongs to the Section Orthopedics)
  • Review
  • Open Access
149 Citations
13,966 Views
27 Pages

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

  • Kazuaki Matsumoto,
  • Kazutaka Oda,
  • Kensuke Shoji,
  • Yuki Hanai and ,
  • Yoshiko Takahashi,
  • Satoshi Fujii,
  • Yukihiro Hamada,
  • Toshimi Kimura,
  • Toshihiko Mayumi and
  • Yoshio Takesue
  • + 7 authors+ 2 authors

Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM), we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical questions were selected. The committee conducted a systematic review and meta-ana...

(This article belongs to the Special Issue Therapeutic Drug Monitoring as a Useful Tool in Therapy Improvement)
  • Article
  • Open Access
13 Citations
3,203 Views
20 Pages

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir

  • Wenyu Yang,
  • Wenyao Mak,
  • Amanda Gwee,
  • Meng Gu and ,
  • Yue Wu,
  • Yufei Shi,
  • Qingfeng He,
  • Xiaoqiang Xiang,
  • Bing Han and
  • Xiao Zhu
  • + 5 authors+ 0 author

Background: Ganciclovir and valganciclovir are used for prophylaxis and treatment of cytomegalovirus infection. However, there is great interindividual variability in ganciclovir’s pharmacokinetics (PK), highlighting the importance of individua...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
463 Views
12 Pages

Population Pharmacokinetics of Subcutaneous Infliximab: A Real-World Study of Naïve and Switch Patients

  • Blanca Vicente,
  • Hinojal Zazo,
  • José Germán Sánchez-Hernández,
  • Natalia Revilla and
  • Paulo Teixeira-da-Silva

Background: Subcutaneous infliximab (SC-IFX) represents a significant advance for patients with inflammatory bowel disease (IBD) due to the possibility of home self-administration. However, at this time, there are no clear recommendations for impleme...

(This article belongs to the Special Issue Personalized Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring, 2nd Edition)
  • Article
  • Open Access
15 Citations
3,413 Views
10 Pages

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases

  • Christian Primas,
  • Walter Reinisch,
  • John C. Panetta,
  • Alexander Eser and ,
  • Diane R. Mould and
  • Thierry Dervieux
  • + 1 author+ 0 author

9 June 2022

Background: Substantial inter-and intra-individual variability of Infliximab (IFX) pharmacokinetics necessitates tailored dosing approaches. Here, we evaluated the performances of a Model Informed Precision Dosing (MIPD) Tool in forecasting trough In...

(This article belongs to the Special Issue New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases)
  • Review
  • Open Access
572 Views
29 Pages

Background/Objectives: Busulfan is a cornerstone conditioning agent for pediatric hematopoietic stem cell transplantation (HSCT), yet its narrow therapeutic index and substantial pharmacokinetic (PK) variability complicate dosing. This review synthes...

(This article belongs to the Special Issue Model-Informed Precision Dosing in Drug Development and Clinical Practice)
  • Article
  • Open Access
11 Citations
5,684 Views
13 Pages

In individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (PopPK) for predictions together with therapeutic drug monitoring (TDM) to maintain adequate objectives is useful to maximize the efficacy and minimize...

  • Perspective
  • Open Access
10 Citations
10,700 Views
14 Pages

22 November 2021

Pharmacokinetics (PK) is a branch of pharmacology present and of vital importance for the research and development (R&D) of new drugs, post-market monitoring, and continued optimizations in clinical contexts. Ultimately, pharmacokinetics can cont...

(This article belongs to the Special Issue Studies of the Dosage Form and Stability of the Drug by Various Techniques)
  • Review
  • Open Access
8 Citations
2,660 Views
24 Pages

Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes

  • Mikhail Parshenkov,
  • Sergey Zyryanov,
  • Galina Rodionova,
  • Anna Dyakonova and ,
  • Petr Shegay,
  • Andrei Kaprin and
  • Grigory Demyashkin
  • + 2 authors+ 0 author

10 December 2025

Background: Major Depressive Disorder (MDD) is a leading global health concern, yet its pharmacological management is hampered by a «trial-and-error» approach, with a significant proportion of patients failing to achieve remission with in...

(This article belongs to the Section Pharmacogenetics)
  • Review
  • Open Access
700 Views
24 Pages

Stewardship Challenges, PK/PD Evidence, and Prescribing Appropriateness for Recently Approved Antibiotics in Pediatric Practice

  • Alessandra Romandini,
  • Chiara Resnati,
  • Stefania Crucitta,
  • Stefano Agliardi and ,
  • Federico D’Amico,
  • Giulia Angela Carla Pattarino,
  • Elena Altieri,
  • Romano Danesi and
  • Costantino De Giacomo
  • + 4 authors+ 0 author

9 September 2026

The rise of multidrug-resistant (MDR) pathogens in the pediatric population represents a significant global health challenge, compounded by a historically stagnant antibiotic pipeline for children. While several novel antibiotics have been approved f...

(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Antimicrobials in Pediatric Patients)
  • Feature Paper
  • Review
  • Open Access
48 Citations
5,456 Views
11 Pages

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics

  • Tina Deyhim,
  • Adam S. Cheifetz and
  • Konstantinos Papamichael

16 November 2023

Biological therapy is very effective for treating patients with moderate to severe inflammatory bowel disease (IBD). However, up to 40% can have primary non-response, and up to 50% of the patients can experience a loss of response to anti-tumor necro...

(This article belongs to the Special Issue New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases)
  • Review
  • Open Access
33 Citations
8,034 Views
17 Pages

Beta-lactams (BL) are the first line agents for the antibiotic management of critically ill patients with sepsis or septic shock. BL are hydrophilic antibiotics particularly subject to unpredictable concentrations in the context of critical illness b...

(This article belongs to the Special Issue Therapeutic Drug Monitoring in Intensive Care)
  • Article
  • Open Access
26 Citations
7,313 Views
15 Pages

Carotenoid Accumulation and the Expression of Carotenoid Metabolic Genes in Mango during Fruit Development and Ripening

  • Witchulada Yungyuen,
  • Thi Thuong Vo,
  • Apiradee Uthairatanakij,
  • Gang Ma and ,
  • Lancui Zhang,
  • Nopparat Tatmala,
  • Samak Kaewsuksaeng,
  • Pongphen Jitareerat and
  • Masaya Kato
  • + 4 authors+ 0 author

7 May 2021

Carotenoids are considered to be important components in mango fruits. However, there is a lack of understanding about the regulation of carotenoids in mango. To gain an insight into the carotenoid metabolism pathway, carotenoid content and the expre...

(This article belongs to the Special Issue Functional Properties in Preharvest and Postharvest Fruit and Vegetables)
  • Article
  • Open Access
1 Citations
1,758 Views
22 Pages

Potential of Sugarcane Biomass-Derived Biochars for the Controlled Release of Sulfentrazone in Soil Solutions

  • Marcos R. F. da Silva,
  • Maria Eliana L. R. Queiroz,
  • Antônio A. Neves,
  • Antônio A. da Silva and ,
  • André F. de Oliveira,
  • Liany D. L. Miranda,
  • Ricardo A. R. Souza,
  • Alessandra A. Z. Rodrigues and
  • Janilson G. da Rocha
  • + 4 authors+ 0 author

21 June 2025

Sugarcane bagasse-derived biochars, produced at 350 °C (B350) and 600 °C (B600), were evaluated for their capacity to modify the sorption behavior of the herbicide sulfentrazone (SFZ) in Red–Yellow Latosol (RYL) and to serve as carriers...

(This article belongs to the Special Issue Environmental Protection and Remediation Processes)
  • Article
  • Open Access
21 Citations
4,992 Views
21 Pages

External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease

  • Christina Schräpel,
  • Lukas Kovar,
  • Dominik Selzer,
  • Ute Hofmann and ,
  • Florian Tran,
  • Walter Reinisch,
  • Matthias Schwab and
  • Thorsten Lehr
  • + 3 authors+ 0 author

Infliximab is approved for treatment of various chronic inflammatory diseases including inflammatory bowel disease (IBD). However, high variability in infliximab trough levels has been associated with diverse response rates. Model-informed precision...

(This article belongs to the Special Issue Model-Informed Precision Dosing)
  • Article
  • Open Access
609 Views
25 Pages

Chemometric Evaluation of Pyrolysis Parameters Affecting Sugarcane Bagasse Biochar Properties for Environmental Remediation

  • Marcos R. F. da Silva,
  • Maria E. L. R. Queiroz,
  • Antônio A. Neves,
  • Antônio A. da Silva and ,
  • André F. de Oliveira,
  • Liany D. L. Miranda,
  • Ricardo A. R. Souza,
  • Alessandra A. Z. Rodrigues and
  • Janilson G. da Rocha
  • + 4 authors+ 0 author

18 August 2026

Biochar has received increasing attention due to its potential to improve soil quality, mitigate environmental contamination, and promote carbon sequestration. However, its properties are strongly influenced by production conditions. In this study, a...

(This article belongs to the Special Issue Environmental Protection and Remediation Processes)
  • Article
  • Open Access
2 Citations
3,422 Views
14 Pages

9 September 2024

P. aeruginosa is the most common microorganism involved in many ICU-acquired infections. A correct dosage regimen is pivotal to avoiding resistance development, worse outcomes and higher mortality rates. The aim of this study was to perform a pharmac...

(This article belongs to the Topic Pharmacokinetic and Pharmacodynamic Modelling in Drug Discovery and Development)
  • Review
  • Open Access
154 Views
53 Pages

Hydroxyurea Pharmacokinetics and Precision Dosing in Sickle Cell Disease: A Scoping Review

  • Amna Mohamed,
  • Jokha Al-Qassabi,
  • Bushra Salman and
  • Khaled Abduljalil

8 November 2026

Background: Hydroxyurea is the cornerstone disease-modifying therapy for sickle cell disease (SCD), but interindividual pharmacokinetic (PK) variability contributes to differences in drug exposure and treatment response. This scoping review synthesis...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
1 Citations
1,105 Views
24 Pages

Mechanistic Artificial Intelligence for Personalized Drug Therapy: Integrating Pharmacokinetics, Pharmacodynamics, Therapeutic Drug Monitoring, and Multiomic Systems Biology

  • Ian Jenkins,
  • Krista Casazza,
  • Waldemar Lernhardt,
  • Valentina Savich and ,
  • Jayson Uffens,
  • Vaishnavi Narayan and
  • Jonathan R. T. Lakey
  • + 2 authors+ 0 author

Interindividual variability in drug response remains a major challenge in clinical pharmacology despite substantial advances in therapeutic drug monitoring (TDM), pharmacogenomics, pharmacokinetics/pharmacodynamics (PK/PD), and model-informed precisi...

(This article belongs to the Special Issue Personalized Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring, 2nd Edition)
  • Article
  • Open Access
4 Citations
2,297 Views
16 Pages

The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program

  • Stephen B. Hanauer,
  • Esther A. Torres,
  • Patricia Aragon-Han,
  • Jonathon C. Chapman and ,
  • Arun C. Swaminath,
  • Ronen Arai,
  • Mandalina Butnariu,
  • Thomas C. Lee,
  • Shervin Rabizadeh and
  • Bincy P. Abraham
  • + 19 authors+ 14 authors

Background/Objectives: This study aimed to establish the clinical utility of a therapeutic drug monitoring (TDM)-supported, model-informed precision dosing (MIPD) approach (precision-guided dosing [PGD]) by assessing the impact of pharmacokinetic (cl...

(This article belongs to the Section Clinical Pharmaceutics)